SCHEMBL4041682

SCHEMBL4041682

NC(=O)Oc1ccc(C[CH]C(=O)N2CCC3C2C(=O)CN3C(=O)c2ccccn2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 4/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CTSL P07711 2/20 0.32
CTSS P25774 2/20 0.32
ADRA1D P25100 1/20 0.32
ADRA1A P35348 1/20 0.32
ADRA1B P35368 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
CCR8 P51685 1/20 0.31
KCNH2 Q12809 1/20 0.31
EPHX2 P34913 2/20 0.31
DRD2 P14416 1/20 0.31
HTR2A P28223 1/20 0.31
RBP4 P02753 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4046518 0.86 ESR1 (0.31)
SCHEMBL4043695 0.83 ELOVL6 (0.35) CTSKCTSLCTSS
SCHEMBL4038909 0.81 STS (0.35) ALDH1A1GAANPC1
SCHEMBL4044468 0.81 L3MBTL1 (0.38) CTSKL3MBTL1CTSLCTSSADRA1D
SCHEMBL4040766 0.81 CTSK (0.40) CTSKL3MBTL1CTSLCTSSADRA1D
SCHEMBL4043899 0.80 PAX8 (0.36) ALDH1A1MAPTKCNH2
SCHEMBL4043000 0.79 CTSK (0.38) CTSKL3MBTL1CTSLCTSSADRA1D
SCHEMBL4042763 0.79 L3MBTL1 (0.33) CTSKL3MBTL1CTSLCTSSADRA1D
SCHEMBL4046128 0.76 KDM4E (0.36) KDM4EALDH1A1NAMPT
SCHEMBL4043363 0.75 DPP4 (0.46) CTSKKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP claimed
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP disclosed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed